- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| LIFESTANCE HEALTH GROUP Aktie jetzt für 0€ handeln | |||||
| 08.11.25 | LifeStance (LFST) Soars 30% on Q3 Earnings Blowout | 1 | Insider Monkey | ||
| 06.11.25 | Lifestance anticipates mid-teens revenue growth for 2026 while raising adjusted EBITDA guidance amid record productivity gains | 6 | Seeking Alpha | ||
| 06.11.25 | LifeStance Health Group, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 06.11.25 | LifeStance Health Group, Inc.: LifeStance Reports Third Quarter 2025 Results | 424 | GlobeNewswire (Europe) | SCOTTSDALE, Ariz., Nov. 06, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| 05.11.25 | LifeStance Health Group, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 23.09.25 | UBS reiterates Buy rating on Lifestance Health stock with $9 price target | 1 | Investing.com | ||
| 23.09.25 | Lifestance Health: UBS bestätigt Kaufempfehlung und sieht 68 % Kurspotenzial | 2 | Investing.com Deutsch | ||
| 22.08.25 | Wechsel im Verwaltungsrat von LifeStance Health: Personette folgt auf Miller | 3 | Investing.com Deutsch | ||
| 22.08.25 | LifeStance Health Group, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 22.08.25 | Wechsel im Verwaltungsrat von LifeStance Health: Sarah Personette folgt auf William Miller | 1 | Investing.com Deutsch | ||
| 22.08.25 | LifeStance Health appoints Sarah Personette to board as Miller steps down | 1 | Investing.com | ||
| 18.08.25 | LifeStance Health (LFST) Accelerates Growth with AI-Enabled Operations and Clinician Expansion | 2 | Insider Monkey | ||
| 15.08.25 | LifeStance (LFST) Extends Rally to 5th Day on Strong Investor Confidence | 1 | Insider Monkey | ||
| 14.08.25 | LifeStance (LFST) Extends 4-Day Run on Strong Earnings | 3 | Insider Monkey | ||
| 08.08.25 | LifeStance raises adjusted EBITDA guidance, targets double-digit margins for full year 2025 while expanding AI and clinician initiatives | 2 | Seeking Alpha | ||
| 07.08.25 | LifeStance Health Group, Inc. - 10-Q, Quarterly Report | 3 | SEC Filings | ||
| 07.08.25 | Earnings Call: LifeStance Health übertrifft Umsatzerwartungen in Q2 2025, Aktie gibt dennoch nach | 4 | Investing.com Deutsch | ||
| 07.08.25 | LifeStance Health Group GAAP EPS of -$0.01 beats by $0.02, revenue of $345.3M in-line | 7 | Seeking Alpha | ||
| 07.08.25 | LifeStance Health Group, Inc.: LifeStance Reports Second Quarter 2025 Results | 459 | GlobeNewswire (Europe) | SCOTTSDALE, Ariz., Aug. 07, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| 06.08.25 | LifeStance Health Gr's Earnings Outlook | 1 | Benzinga.com |
1 2 Weiter >>
24 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 47,730 | -2,55 % | Amneal Pharma, MAbxience: FDA Approves Denosumab Biosimilars Referencing Amgen's Prolia And XGEVA | THOUSAND OAKS (dpa-AFX) - Amneal Pharmaceuticals, Inc. (AMRX) announced late Monday that the U.S. Food and Drug Administration has approved the Biologics Licensing Applications or BLAs for Boncresa... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,170 | -1,45 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 44,140 | -1,74 % | JEFFERIES stuft Siemens Healthineers auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Siemens Healthineers vor Zahlen zum ersten Geschäftsquartal auf "Buy" mit einem Kursziel von 60 Euro belassen. Der Medizintechnikkonzern... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 39,620 | -0,95 % | EILMELDUNG: Carl Zeiss Meditec-Aktie stabil - Marktbeobachter rechnen mit Bewegung. | ||
| TELADOC HEALTH | 5,977 | +1,22 % | Teladoc Health, Inc.: Teladoc Health Announces Chief Financial Officer Transition | NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced that Mala Murthy will be stepping down from her role as Chief Financial... ► Artikel lesen | |
| ROKU | 93,29 | -1,03 % | Citizens reiterates Market Outperform rating on Roku stock at $145 target | ||
| DEXCOM | 56,57 | -1,31 % | DexCom, Inc.: Listening to Healthcare Professionals: Dexcom Launches New Education Offering, Dexcom Academy | New personalised learning platform aims to build confidence in healthcare professional (HCP) CGM knowledge, no matter their previous experience, and support high-quality diabetes care. ... ► Artikel lesen | |
| INMODE | 12,700 | +0,32 % | InMode Ltd.: InMode Reports Third Quarter 2025 Financial Results: Quarterly Revenue of $93.2 Million, 78% Gross Margins | YOKNEAM, Israel, Nov. 5, 2025 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced... ► Artikel lesen | |
| PETMED EXPRESS | 2,853 | -1,14 % | PetMed Express, Inc.: PetMed Express Comments on Unsolicited and Non-Binding Acquisition Proposal Received From SilverCape Investments Limited | DELRAY BEACH, Fla., Dec. 11, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., d/b/a PetMeds and parent company of PetCareRx, (Nasdaq: PETS) (the "Company" or "PetMeds"), today confirmed that it has... ► Artikel lesen | |
| ORGANON | 6,282 | +3,70 % | Dividendenbekanntmachungen (20.11.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ALLIENT INC US0193301092 0,03 USD 0,0259 EUR APPLIED MATERIALS INC US0382221051 0,46 USD 0,3986 EUR APPLIED MATERIALS INC CDR CA03822G1046 0... ► Artikel lesen | |
| TANDEM DIABETES | 18,875 | +0,21 % | TANDEM DIABETES CARE INC - 8-K, Current Report | ||
| INSULET | 240,00 | -1,72 % | Is it the Right Time to Add Insulet Stock to Your Portfolio? | ||
| QUIDELORTHO | 23,800 | -4,80 % | QuidelOrtho Corporation: QuidelOrtho Reports Third Quarter 2025 Financial Results | ? Total revenue of $700 million; excluding COVID-19 and Donor Screening, revenue grew mid-single digits, demonstrating solid underlying growth and momentum ? ... ► Artikel lesen | |
| MOLINA HEALTHCARE | 153,85 | +5,38 % | Molina Healthcare Stock Breaks Above Its 100-Day Moving Average as Michael Burry Pounds the Table on MOH | ||
| CLOVER HEALTH INVESTMENTS | 2,073 | -1,05 % | Clover Health Investments, Corp.: Clover Health Announces Chelsea Clinton to Step Down from Board Following Eight Years of Service | WILMINGTON, Del., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) ("Clover," "Clover Health" or the "Company") today announced that Chelsea Clinton, the longest-serving... ► Artikel lesen |
Das Unternehmen LIFESTANCE HEALTH GROUP INC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 6,955 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu LIFESTANCE HEALTH GROUP INC finden Sie auf Wallstreet Online.